SCHEMBL20568657

SCHEMBL20568657

CN1CCCN(c2cc(N)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.47
HRH4 Q9H3N8 4/20 0.44
ADRB1 P08588 1/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
PTK2B Q14289 2/20 0.44
GFER P55789 1/20 0.44
KMT2A Q03164 1/20 0.44
ESR2 Q92731 1/20 0.44
NR2E1 Q9Y466 1/20 0.43
CHKA P35790 1/20 0.40
MAPK1 P28482 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL273503 0.94 ADRA2C (0.53) ADRA2CHRH4ADRB1ALDH1A1MAPT
SCHEMBL23113436 0.89 ADRB1 (0.53) ADRB1ALDH1A1MAPTKDM4EGAA
SCHEMBL1603395 0.86 ADRB1 (0.53) ADRB1ALDH1A1MAPTKDM4EGAA
SCHEMBL7784808 0.86 ALDH1A1 (0.46) ADRA2CHRH4ADRB1ALDH1A1MAPT
SCHEMBL2051137 0.84 ADRB1 (0.51) ADRB1ALDH1A1MAPTKDM4EGAA
SCHEMBL10104302 0.84 ADRB1 (0.45) HRH4ADRB1ALDH1A1CHKAMET
SCHEMBL12968839 0.82 ADRB1 (0.61) ADRA2CADRB1ALDH1A1MAPTKDM4E
SCHEMBL20568131 0.78 IDO1 (0.47) ADRB1ALDH1A1MAPTKMT2AMAPK1
SCHEMBL2311467 0.78 GAA (0.53) ADRB1ALDH1A1MAPTKDM4EGAA
SCHEMBL16904563 0.78 ADRB1 (0.45) ADRA2CADRB1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630778-A1 NOVEL INHIBITORS OF MAP4K1 Ichnos Sciences SA (CH) 2020-04-08 EP disclosed
WO-2018215668-A1 NOVEL INHIBITORS OF MAP4K1 GLENMARK PHARMACEUTICALS S.A. (CH) 2018-11-29 WO disclosed